cccDNA
生物
肝细胞癌
实时聚合酶链反应
数字聚合酶链反应
核酸外切酶
病毒学
分子生物学
核酸外切酶 III
环状DNA
聚合酶链反应
检出限
DNA
癌症研究
乙型肝炎病毒
基因
聚合酶
病毒
基因组
化学
遗传学
大肠杆菌
乙型肝炎表面抗原
色谱法
作者
Zhuo Wang,Yanmeng Chen,Haijun Deng,Xiaochuan Zhen,Jing Xiong,Yuan Hu
标识
DOI:10.1016/j.jviromet.2021.114334
摘要
The quantification of intrahepatic covalently closed circular DNA (cccDNA) is important for assessing the efficiency of anti-HBV therapy. Exonuclease treatment is essential before real-time quantitative PCR (qPCR) or droplet digital PCR (ddPCR) measurement to improve the specificity of cccDNA quantification. In this research, we compared the limit of detection (LOD) of qPCR and ddPCR and evaluated the digestion efficiency of three exonuclease treatments, PSAD, exonuclease III and T5 exonuclease, when measuring cccDNA in cells or clinical samples by ddPCR. We demonstrated that the LOD of ddCPR was 5.9 copies/reaction, which was much lower than that of qPCR (54.9 copies/reaction), indicating that ddPCR is more sensitive than qPCR. Meanwhile, compared to PSAD or Exo III, UNG and T5 exonuclease treatment combined with ddPCR is more effective in detecting intrahepatic cccDNA in clinical samples. Finally, the median intrahepatic cccDNA was 2.6 copies/104 cells in 26 pairs of HCC samples determined by the improved ddPCR method. Therefore, we developed an optimized ddPCR method, which can be used for the absolute quantification of low levels of intrahepatic cccDNA more precisely.
科研通智能强力驱动
Strongly Powered by AbleSci AI